INS and diabetes mellitus: A new class of diabetes drugs has been developed: SGLT-2 inhibitors, which allow the kidneys to excrete more glucose; GLP-1 agonists, which increase insulin secretion; and iminosugars, such as 1-deoxynojirimycin, found in mulberry, which can inhibit gut glucosidase [13].